While this was a proof-of-principle study in which restoration of p53 in Mdm2-overexpressing angiosarcomas shows efficacy, the p53 genotype was such that p53 was restored in both Cre-expressing tumor and normal cells. This evidence concerns the gene TP53 and angiosarcoma.